Kishwar Azad, MRCS, LRCP, FCPS, MSc, to Receive American Diabetes Association’s 2017 Vivian Fonseca Scholar Award
June 5, 2017
Kishwar Azad, MRCS, LRCP, FCPS, MSc, FRCPCH (Hon), has been selected to receive the American Diabetes Association® (Association) 2017 Vivian Fonseca Scholar Award. The Vivian Fonseca Scholar Award recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations, and/or research by a scientist from these areas in memory of Mr. P. Nagendran. The Award honors the contributions of Dr. Vivian Fonseca, a former President, Medicine & Science of the American Diabetes Association; the Tullis-Tulane Alumni Chair in Diabetes; and Professor of Medicine Chief in the Section of Endocrinology at Tulane University School of Medicine who has been a mentor and role model to many researchers and clinicians and continues to serve the Association and the diabetes community in our quest for advances in diabetes care.
Dr. Azad will receive this honor during the Association’s 77th Scientific Sessions, June 9-13, 2017, at the San Diego Convention Center in recognition of her abstract, “The Burden of Diabetes, Hypertension, and Noncommunicable Disease Risk Factors among Adults Aged 30 Years and Above in Rural Bangladesh―A Cross-Sectional Epidemiological Survey.” The abstract will also be the topic of her Vivian Fonseca Award Lecture on Sunday, June 11.
Dr. Azad is the project director of the Diabetic Association of Bangladesh―Perinatal Care Project, a collaborative program between the Diabetic Association of Bangladesh, University College London Institute of Global Health, and Women and Children First, a UK-based charity. She is also Professor of Paediatrics at the Ibrahim Medical College and Senior Honorary Consultant, Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, in Dhaka, Bangladesh.
“Thank you, Dr. Azad, for your efforts to reduce the cost barriers to neonatal, child and maternal health care for underserved populations and poor countries,” said the Association’s President of Medicine and Science of Alvin C. Powers, MD. “Your innovative work has had an impressive impact on the lives of many people. Congratulations on this honor.”
In addition to publications on neonatal health, diabetes and health systems, Dr. Azad is a member of several professional organizations and was President of the Bangladesh Neonatal Forum. Beyond her professional endeavors, Dr. Azad also lends her expertise to the development of strategies and guidelines on neonatal, child and maternal health, and childhood and adolescent diabetes. She was awarded an Honorary Fellowship from the Royal College of Paediatrics and Child Health and was made an Honorary Senior Research Associate of University College, London. Dr. Azad’s other research interests include epidemiology and aetiology of childhood diabetes in Bangladesh, and fetal origins of adult diabetes.
The Vivian Fonseca Scholar Award is supported by a grant from Suku Nagendran, MD, and Anne Nagendran.
The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE¹, President of Health Care and Education, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts. Join the Scientific Sessions conversation on Twitter, #2017ADA.
About the American Diabetes Association
More than 30 million Americans have diabetes, and every 21 seconds another person is diagnosed with diabetes. The American Diabetes Association (Association) is the global authority on diabetes and since 1940 has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. To tackle this global public health crisis, the Association drives discovery in research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and provides support and advocacy for people living with diabetes, those at risk of developing diabetes and the health care professionals who serve them. For more information, please call the American Diabetes Association at 1-800-DIABETESS (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)
1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.